The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) under the Ministry of Ayush conducted a five-day Capacity Building Training Program
Program duration: May 18 to 22, 2026
Location: New Delhi
Target audience: Drug Enforcement Officers, Quality Control Personnel and manufacturers of Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs
Total participants: 28 from regulatory bodies, research councils, pharmaceutical industries and academic institutions across the country
First two days: Technical sessions on pharmacognostic identification of ASU&H drugs, phytochemical analysis and Good Manufacturing Practices (GMP)
First two days: Hands-on laboratory training in Pharmacognosy and Chemistry laboratories
Third day: Lectures on shelf-life studies and regulatory frameworks
Third day: Industry visits to Dr. Willmar Schwabe India Pvt. Ltd. and Hamdard Laboratories
Fourth day: Sessions on microbiological evaluation and regulatory aspects with practical laboratory training
Fifth day: Focus on pharmacological studies, GMP and standardization of metal and mineral-based drugs
Inaugural session attendees: Jaspal Kaur Pradyot (Chief Controller of Accounts, Ministry of Health & Family Welfare) as Chief Guest, Abdul Qayum (Director (Technical) & Deputy CEO, National Medicinal Plants Board, Ministry of Ayush) as Guest of Honour, Raman Mohan Singh (Director, PCIM&H)
Valedictory session attendees: Maneesha Upendra Kothekar (Chairperson, National Commission for Indian System of Medicine) as Chief Guest, Pramod Kumar Pathak (Principal Consultant & Retd. Special Secretary, Ministry of Ayush) as Guest of Honour
Program combined expert lectures, practical laboratory training and field exposure
Focus areas: pharmacopoeial standards, GMP and regulatory frameworks
Objective: Strengthening regulatory understanding, enhancing technical capabilities and promoting quality assurance mechanisms in the ASU&H drug sector
